Trial Profile
Individualized Therapy For Asthma in Toddlers
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Mar 2017
Price :
$35
*
At a glance
- Drugs Fluticasone propionate (Primary) ; Montelukast (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms INFANT
- 06 Apr 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 10 Jul 2014 Planned Primary Completion Date changed from 1 Jan 2015 to 1 Mar 2015 as reported by ClinicalTrials.gov record.
- 10 Jul 2014 Planned End Date changed from 1 Jan 2015 to 1 Mar 2015 as reported by ClinicalTrials.gov record.